Chemed Corporation $CHE Shares Sold by Bridges Investment Management Inc.

Bridges Investment Management Inc. lessened its position in shares of Chemed Corporation (NYSE:CHE) by 6.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 61,869 shares of the company’s stock after selling 4,238 shares during the quarter. Bridges Investment Management Inc. owned 0.44% of Chemed worth $26,471,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in CHE. Smartleaf Asset Management LLC boosted its stake in Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. acquired a new position in Chemed during the fourth quarter worth $27,000. Global Retirement Partners LLC boosted its stake in Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after buying an additional 58 shares during the last quarter. Rothschild Investment LLC increased its stake in Chemed by 800.0% during the fourth quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock worth $46,000 after acquiring an additional 96 shares during the last quarter. Finally, Danske Bank A S increased its stake in Chemed by 250.0% during the fourth quarter. Danske Bank A S now owns 140 shares of the company’s stock worth $60,000 after acquiring an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares in the company, valued at $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 3.33% of the stock is currently owned by company insiders.

Chemed Stock Down 1.2%

NYSE:CHE opened at $417.62 on Wednesday. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. The stock’s fifty day moving average is $405.05 and its two-hundred day moving average is $424.82. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $570.34. The stock has a market capitalization of $5.54 billion, a price-to-earnings ratio of 22.76, a price-to-earnings-growth ratio of 1.59 and a beta of 0.54.

Chemed (NYSE:CHE) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The company had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm’s revenue was up 1.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Research analysts anticipate that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be paid a $0.60 dividend. The ex-dividend date is Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s payout ratio is 13.08%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CHE. Oppenheimer cut their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Royal Bank Of Canada raised their target price on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Wall Street Zen raised Chemed from a “hold” rating to a “buy” rating in a research note on Sunday. Finally, Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Chemed presently has a consensus rating of “Hold” and an average target price of $501.50.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.